Drug Search Results
More Filters [+]

homatropine

Alternative Names: homatropine
Latest Update: 2015-01-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Bangladesh | Canada | Chile | Greece | Hong Kong | India | Indonesia | Ireland | Korea | Mexico | New Zealand | Pakistan | Philippines | Portugal | Slovenia | Taiwan | United Kingdom | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for homatropine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title